We mitigate risk in the clinical trials process
There are hidden costs within the clinical trials process that can quickly develop into disasters without careful planning and execution. Delays in the trial due to supply chain errors can lead to enormous intangible and tangible costs for pharmaceutical companies while overly optimistic buying programs can lead to waste in excess materials.
Ancillare mitigates these risks for our customers and provides a much more consistent and proven approach to the clinical trials process, avoiding potential costs before they materialize. Our APTs work directly with our customers, their investigator site locations, and suppliers to create buying programs based on expected and actual demand as the trial progresses. Our unique demand analysis programs provide forecasts for patient allotment and distribution throughout the trial to avoid delays in trial implementation.
Our warehousing and controlled storage facilities allow us to store reserves of materials to distribute should unexpected scenarios arise. Our global logistics expertise allows us to manage the distribution process, working only with suppliers and carriers that perform flawlessly in the field. Lastly, our Ancillare Research and Development Management System (ARDMS) creates the dashboard necessary to manage a global process effectively and efficiently.
As a result of an Ancillare partnership, we eliminate supply chain risk and manage the supply chain to ensure that trials are completed successfully, both on time and cost-effectively.
